THE INDUSTRY SHAPING AGENDA

200+ SPEAKERS  |  150+ SESSIONS  |  20+ WORKSHOPS  |  6 STAGES

To navigate the agenda first please select your areas of interest from the left hand side tick box.

The agenda is decided to foster movement and flow between different stages to break down silos and sparking new collaborations.  

2:30pm–5:30pmAC Hotel

Workshop Choice 1: How business leaders can beat the talent crunch: Leading across generations

For pharma business leaders to thrive in today’s competitive market, as well as meet the needs of our patients, it is vital to not only attract the best candidates but it’s equally critical to retain your top talent. This practical workshop is for anyone leading a team in pharma who wants to know how to proactively develop their team’s talents, retain staff and be a more effective, influential and impactful leader.

Workshop participants will:

  • Learn new skills for being an effective, engaging and influential leader–with insights from cross-generational individuals
  • Gain tools for adjusting your leadership style for the cross-generational workforce
  • Learn from other business leaders on how they have been able to keep staff in-house and not lose them to the competition
  • Understand how to “take stock” of the leadership capabilities and assess whether your teams are equipped with the optimal mindset–one that is innovative, agile and collaborative–and tools to beat the “war on talent”
  • Explore how to build and leverage networks via the Healthcare Businesswomen’s Association (HBA) as inspiration to enhance professional success of your employees
  • Discover how to be an attractive employer that fosters inclusion and diversity

Sabine Hutchison HBA Europe Deputy Chair and CEO of Seuss Healthcare Business Women's Association

Kathrin Schoenborn HBA Europe Chair and VP, Head of Integrated Planning, Analytics and Partnering Merck KGaA

2:30pm–5:30pmAC Hotel

Workshop Choice 2: Strategic Account Management (SAM) in pharma

Our workshop will show a proven alternative approach to co-create value with and become strategic to your largest and most important customers. The Strategic Account Management Association will run a short introductory session to reach a common understanding on the principles of SAM where successful practitioners will share not only what they did, but how they did it in a highly interactive session.

Workshop participants will:

  • Identify the 11 key enablers of a SAM Program
  • Discover how to select the right companies as strategic accounts and why this is so critical to get it right the first time
  • Understand how to gain internal support for a SAM program
  • Learn how to measure the organizational impact
  • Hear from pharmaceutical executives sharing their challenges and success factors in SAM and KAM

Max Walker Director, Strategic Account Management, CVG EMEA Medtronic

Dominique Cote Board Member The Strategic Account Management Association

Denise Freier CEO The Strategic Account Management Association

Harvey Dunham Management Director of Strategy & Marketing The Strategic Account Management Association

5:30pm–7:30pm | AC Hotel

Pre-Day Icebreaker Networking Drinks

Sign-up here for the pre-day workshop

7:30am–8:45am | Exhibition Hall

Registration & meet your peers for a welcome coffee

8:50am–9:05amGreen Room

Where Pharma Comes to Life

9:05am–12:20pmGreen Room

Opening c-suite keynote sessions

Key themes include:

  • Authentic Leadership: ensure integrity and accuracy in decision-making and portfolio design. Gain healthcare’s trust through medically-driven content, customer innovation and holistic patient solutions
  • New ways to reach commercial goals: turn HCPs into influencers and inspire patient champions. Use content, education, empowerment and open innovation to harness external relationships
  • From drugs to treatments: use cloud platforms, data insights and joint ventures with startups to generate a new suite of digital products, value-added services and cell/gene therapies. Go from druggable & reactive to curable & preventative
  • Digitise evidence: prepare a superior mix of virtual clinical trials and regulatory-grade RWE to gain authorisation, widen access, boost launch and drive patient outcomes

More session details to follow

Bertrand Bodson Chief Digital Officer, Member of the Executive Board Novartis

Kris Sterkens Company Group Chairman, Janssen EMEA Janssen

Chris Round EVP, Head of International Operations & Global Core Franchises Merck

Sven Dethlefs EVP, Global Marketing & Portfolio Teva

Jassi Chadha CEO Axtria

Paul Simms Chairman eyeforpharma by Reuters Events

10:45am–11:10amGreen Room

The Health Start-Up Challenge Final

Our 6 startup finalists each have just three minutes to demonstrate disruption and win your support to win the crown as 2020 Health Start-Up of the Year

10:55am–11:40amOrange Room

Where is tech innovation bringing real value in healthcare – and how are pharma companies keeping pace?

  • In which areas are new tech advances driving innovation in healthcare? How do pharma companies need to adapt to stay relevant?
  • Discover how strong data analysis is now seen as a core competency and where it can reveal unseen insights to add significant business value
  • Learn how integrating AI, blockchain, VR/AR and other emerging technologies is accelerating productivity and efficiencies across the industry
  • Understand how working with startups can accelerate digital innovation and foster new ways of working for better overall outcomes

Michelle Shogren Director of Innovation - Pharma R&D Clinical Operations Bayer

Ali Abusnina Senior Data Scientist Boehringer Ingelheim BI X Digital Lab

Haider Alleg Global Head of Digital Excellence Ferring

Gail Gannon Managing Director WaveEdge Capital

Amy Peck Founder & CEO EndeavorVR

12:00pm–12:20pmOrange Room

The future of AR & VR in Biopharma

  • Learn how virtual, augmented & mixed reality (XR) are poised to disrupt healthcare and pharma practices in meaningful ways
  • Get a high-level overview of XR technologies and hardware, an understanding of use cases & programs in operation, and potential integration with tech such as blockchain and AI going forward
  • Hear the current capabilities and near-term evolution of XR and how companies are leveraging the technology across business lines from R&D, simulation & training, digital therapeutics, manufacturing and more

Amy Peck Founder & CEO EndeavorVR

12:00pm–12:20pmPurple Room

LEO Innovation Lab: how a new clinical paradigm was created within a 110-year old company

  • How an open-minded approach to evidence enabled the identification of new subtypes of diseases through RWD
  • A guide to successful remote clinical trials in dermatology and how this was done in an Innovation Lab, separate to the mothership
  • Simplicity is key: avoid complexity on the most complex treatments and ensure your trials don’t add to the EHR burden through careful management

Rasmus Hogreffe Head of Virtual Clinical Trials LEO Innovation Lab

12:20pm–1:50pm | Exhibition Hall

Lunch, networking session and interactive solution zone

1:55pm–2:15pmOrange Room

Artificial Intelligence – Cutting through the hype to real, impactful and successful implementation

  • What can AI offer to an industry already knee deep in technology? How does its emergence differ from other tech advances we have seen? How is it similar?
  • Hear how artificial intelligence is allowing rapid, accurate and specific discovery for areas of huge unmet medical need
  • Discover why Nuritas believes AI is already beginning to transform pharma R&D and drug discovery – and at the same time open up a new and huge reservoir of potent drug candidates with potentially greater approval prospects
  • Get examples of real-life data and results to demonstrate the benefits of AI across a number of drug discovery and development projects

Emmet Browne CEO Nuritas

1:55pm–2:15pmBlue Room

Targeting patient engagement across the lifecycle

  • Building on executive buy-in to enable an all-inclusive, company-wide approach to patient engagement – a must in the rare disease sector
  • Why an online resource for employees across functions and geographies can help facilitate and support patient engagement
  • A case study and techniques for transferring and translating knowledge between disease areas and between physicians of a successful approach between disease areas

Lutz Bonacker SVP & General Manager, Commercial Operations Europe CSL Behring

1:55pm–2:15pmGreen Room

Driving value – the evolving strategic role of Medical Affairs

  • Connect science, clinical outcomes and patient value to build a future-fit Medical Affairs function
  • Build a positive reputation and drive scientific exchange with an ever-expanding external stakeholder community
  • Identify, optimize and integrate external insights to inform medical/corporate strategy and enhance value delivery
  • Deliver strategic impact for the C-Suite as a business savvy and agile partner

Charlotte Kremer EVP, Head of Medical Affairs Astellas

1:55pm–2:15pmPink Room

Real-world data as the trust catalyst for partnerships between pharma and healthcare systems

  • How RWD has played a critical role in establishing trusted partnerships
  • How to achieve better patient outcomes through RWE driven collaborations
  • Why RWD is the key to a performance based system, driven by real-time real-world insights

Michael Seewald VP, Global Evidence, Medical AstraZeneca

1:55pm–2:15pmPurple Room

Patient involvement from the beginning, not the endpoint

  • How to ensure the patient perspective is always the driver, not the follower, despite the increasing prioritization of technological innovation
  • Identify the gaps in your understanding that you need to fill in order to ensure you have identified stage-gate specific goals that need to be informed by the patient perspective
  • A look at Biogen’s 5-step process used to develop a PFDD strategy, with examples of key questions and methodology/tools

Isabela Niculae R&D Portfolio Transformation Leader Biogen

1:55pm–2:55pmRoundtable Zone

Market Access Rountables

  • Join colleagues from across the industry for a 60 minute in-depth discussion of the most pressing issues in Market Access today

2:15pm–2:35pmOrange Room

Just Imagine! Empowering patients and alleviating healthcare system pressure with AI

  • Hear the latest progress on how LEO Innovation Lab’s Imagine platform aims to use Artificial Intelligence to diagnose skin at the same level as expert dermatologists
  • Find out how users can use the platform to track skin lesions as they change over time by taking photos with their smartphone
  • Understand how this empowers patients to draw correlations with lifestyle triggers, assess the efficacy of treatments, and to find the optimal treatment and lifestyle as fast as possible
  • Discover how the technology has the potential to relieve the mounting pressure on doctors, improve access to quality care and alleviate the strain of chronic skin conditions on public healthcare infrastructure

Kristian Hart-Hansen CEO LEO Innovation Lab

2:35pm–2:55pmBlue Room

If you think you’re patient-centric, you’re probably only halfway there

  • Case Study: How Novo Nordisk developed next generation support programmes by engaging their patient partners to identify and then solve critical unmet needs for those with diabetes
  • Learn from your mistakes: An honest assessment of how to identify flaws in your frameworks when approaching patient support in different socio-economic, cultural and healthcare systems

Jenna Copeland Kristensen Global Director, Patient Support Programmes Novo Nordisk

2:35pm–2:55pmRed Room

Case Study: How to initiate an effective turnaround plan that cascades through your business

  • Identify the obstacles you face when changing your core business model and how to overcome them
  • See the process Allergopharma used to identify the best of commercial pharma which it wanted to adopt – and the areas that were avoided

Philipp Maerz CEO Allergopharma

2:35pm–2:55pmGreen Room

Future-proof medical affairs: how to evolve into an agile, customer-driven function

  • Medical Governance frameworks to structure around the customer, internal and external, to co-create and present value
  • Excel in an algorithm and data driven healthcare decision-making system

Michael Zaiac Head of Medical Affairs, Oncology, Europe Novartis

2:35pm–2:55pmPink Room

Real-world evidence: the disruptor enabling brand differentiation

  • Why RWE influences a brand strategy, not just a payer strategy
  • How RWE brings together the HCP community
  • Role of a cross-functional collaboration in RWE-generation to serve more patients

Victoria Williams Vice President, Respiratory Medicine Commercialisation Leader GSK

2:35pm–2:55pmPurple Room

Patient-centric trials are digital trials

  • Use technology to create patient-preferred trials – the trials patients would choose. Integrate new processes to modernise the delivery of development
  • Raise your status with patient community with more ambitious endpoints, aligned goals and a new Standard of Care

Sebastian Stratmann Senior Manager, Clinical Innovation Merck

2:55pm–4:05pmWorkshop Rooms

Break-Out Interactive Workshop Sessions (Pharma and Biotech only)

  • Pick from 10 different interactive break-out sessions fostering hands-on learning and open discussion in a more personal setting
  • Sign up for these limited space sessions via the \"interactive sessions\" section of your eyeforpharma Barcelona app

2:55pm–3:20pmOrange Room

How blockchain technology could reinvent the pharmaceutical supply chain

  • Hear the latest on the Innovative Medicines Initiative Programme “Blockchain Enabled Healthcare”, a consortium approach to establish the use of blockchain in the healthcare industry
  • Find out why Novartis see blockchain technologies having the potential to hugely improve third party risk management
  • Learn how agreed and standardised digital identifiers can reduce admin and streamline processes across the entire supply chain
  • Discover where else blockchain is starting to make a real impact on workflows in drug and treatment lifecycles

Marco Cuomo Manager, Applied Technology Innovation Novartis

Daniel Fritz Domain Architect Supply Chain & External Supply Novartis

3:20pm–3:50pmOrange Room

Health Start-Up Panel

Learn from the Health Start-Up challenge companies on how their innovating and setting prioirites for the future of healthcare

4:05pm–4:35pm | Exhibition Hall

Coffee break, networking sessions and interactive solution zone

4:35pm–4:55pmBlue Room

Know your audience: develop tools that patients can understand

  • Drastically improve your educational tools by engaging the right patients to establish where their knowledge gaps are and how to fill them
  • The simpler, the better: ease HCPs workload by developing materials that make delivery seamless and help patients articulate their needs

Christina Claussen Director, Alliance Management & Patient Relations Pfizer

Eva Schumacher-Wulf Patient Advocate & Editor-In-Chief Mamma Mia! Magazine

4:35pm–4:55pmRed Room

Case Study: walk in your customer’s shoes: understand every step of the customer journey to provide personalised CX

  • Build a complete picture of your customer by tracking all interactions, not just those with your own brands
  • Focus on the motives of your physicians’ actions to ensure you provide the service they need most effectively

Steve Skyrme Global Lead, Customer Experience, Oncology Pfizer

4:35pm–4:55pmGreen Room

Empower your medical field force and fulfil stakeholder need

  • Don’t limit your MSLs to HCPs: define their new role on the frontline of pharma’s field force expanding across patient groups and market access authorities
  • MSLs aren’t superhuman: help them realise their full potential with a clear overall field-team strategy, whilst building capabilities in key business operational and soft skills
  • Ensure MSLs are not tongue-tied with a defined company compliance and medical governance framework

Emma Booth Director, Head of Medical Strategy and Operations Amgen

4:35pm–4:55pmPink Room

HARMONY: Enhancing patient care and R&D decision-making through integration of pan EU haematological data

  • How the IMI HARMONY Consortium overcame data anonymisation, harmonisation and privacy challenges to integrate clinical, genomic and registry data into a single Big Data Platform
  • The reality and future promise of Big Data approaches to unanswered medical questions
  • Future expansion through greater RWD integration to enable synthetic control armed trials, expanded patient representation and hypothesis generation to support new study design

Pam Bacon Executive Director, Global Medical Affairs Celgene

4:35pm–4:55pmOrange Room

Linking AI with advanced validated digital biomarkers to improve patient outcomes

  • Understand how the development of advanced digital biomarkers enables better measurement, monitoring and management of diseases
  • Discover how enhanced data science techniques are helping to HCPs deliver highly personalized healthcare
  • Learn about the key roles AI and machine learning play in discovering and interpreting complex patterns in enormous data sets to create digital biomarkers

Bert Seegers Chief Business Officer Orikami

4:35pm–4:55pmPurple Room

How to create virtual trial participants

  • Understand the rationale and criteria for building virtual trial cohorts and compensate for lack of participant data
  • A journey through Ipsen’s process in building evidence with translational approaches, mixing RWE and clinical data, adding genomics, metabolomics and validating with the FDA
  • Use this aggregated information and high-quality algorithms to create predictions and best target identification

Stephane Orssaud R&D Biometry Innovation Director Ipsen

4:35pm–4:55pmRoundtable Zone

Digital/Marketing Roundtables

Join colleagues from across the industry for a 60 minute in-depth discussion of the most pressing issues in Marketing and Digital today

4:55pm–5:15pmOrange Room

Inside out innovation: How Ferring is creating the next generation of business models and solutions by pioneering with an eco-system of innovative start-ups & tech players

  • Understand how your company can leapfrog into disruptive business models
  • To succeed, you must first fail: grasp how commercial innovation and positive failure are intrinsically linked
  • Explore how to structure the organisation to develop commercial agility

Haider Alleg Global Head of Digital Excellence Ferring

4:55pm–5:15pmGreen Room

Advancing Clinical Practice: Medical Affairs Innovation Show and Tell

  • How to shape your medical affairs function to match the needs of new medical advancement
  • Through case-study examples of immersive storytelling, data visualization, interactivity and digital planning, learn how to address key drivers of change using meaningful innovation

Greg Imber Chief Engagement Officer HCG

4:55pm–5:05pmPurple Room

How to lower costs and speed up clinical studies with structured clinical data, electronic patient files and collaborative marketplaces

  • Learn current solutions to speeding up clinical trials and lowering costs in study set-up, execution and collaboration
  • Discover how pharma companies can find more hospitals and recruit patients more quickly with a marketplace for clinical studies
  • Understand how pharma companies can utilize FHIR based structured clinical data and electronic patient files to have live data in their studies

Stefan Wiesner CEO Healex

5:15pm–5:55pmBlue Room

No trust, No Data – Education and collaboration

  • Case Study: How the new #DataSavesLives EPF initiative is improving patient perspectives on data use by providing complex information in an understandable and accessible way
  • Understand the importance of trust in improving data sharing attitudes as patient ownership increases

Nicola Bedlington Special Advisor European Patients Forum

Brendan Barnes Director IP & Global Health EFPIA

5:15pm–5:55pmRed Room

What culture and capability changes are required to accelerate digital adoption throughout your organisation

  • Encourage greater digital implementation amongst laggard teams by using metrics and KPIs that more tangibly demonstrate long-term impact
  • Create a global strategy that evolves to meet local affiliate constraints and specific customer requirements, whilst reducing duplication of effort

Florent Edouard SVP, Global Head of Commercial Excellence & Customer Engagement Grünenthal

Abel Archundia SVP, Global Head of IT & Digital Transformation Bayer

5:15pm–5:55pmGreen Room

Panel: Conduct your evidence symphony - a new paradigm to align cross-company evidence generation around outcomes

  • Better identify study gaps and requirements with Medical becoming the transceiver of scientific information across RWE studies and clinical trials
  • Why every company should centralise company evidence generation strategy to be led by Medical Affairs

Niko Andre Head of Global Medical Affairs Roche

Klaus Dugi EVP, Chief Medical Officer Ferring

Michael Seewald VP, Global Evidence, Medical AstraZeneca

Pol Vandenbroucke SVP, Chief Medical Officer, Hospital Business Unit Pfizer

Charlotte Kremer EVP, Head of Medical Affairs Astellas

5:15pm–5:55pmPink Room

Panel: Amplify research opportunities with integrated RWD systems – learning from IMI’s BD4BO

  • How IMI’s EHDEN project is progressing in building a federated data networking across Europe using a common model, with key achievements and objectives
  • How the PIONEER initiative is creating a standardised data platform for prostate cancer, combining clinical and RWD sources, to enable greater therapeutic area research capabilities
  • Why standardisation is key in a world of linkage and AI/ML capabilities, and how these different approaches work in unison
  • Ensure data availability - approaches to increasing data holder’s willingness to share centralised data

Nigel Hughes Scientific Director Janssen

5:15pm–5:35pmPurple Room

Linking AI with advanced validated digital biomarkers to improve patient outcomes

  • Understand how the development of advanced digital biomarkers enables better measurement, monitoring and management of diseases
  • Discover how enhanced data science techniques are helping to HCPs deliver highly personalized healthcare
  • Learn about the key roles AI and machine learning play in discovering and interpreting complex patterns in enormous data sets to create digital biomarkers

Bert Seegers Chief Business Officer Orikami

5:35pm–5:55pmPurple Room

How virtual reality is impacting the treatment of mental health

  • Understand the very real power of virtual reality (VR) to help treat a whole range of mental health conditions
  • Discover how it's already supporting the treatment of depression, phobias and other anxiety disorders
  • Find out how both therapists and patients can benefit from using VR to better choose effective treatment pathways
  • Hear how VR is being best used as a companion treatment alongside traditional medicines and the results clinicians are seeing

Xavier Palomer CEO Psious

5:15pm–5:55pmOrange Room

Panel: IMI Trials@Home: Reshaping Remote Decentralised Clinical Trials in Europe

  • How to analyse previous centralised/RDC/hybrid trials and develop best-practice protocols to enable a pan-EU pilot
  • Ensure smart, complaint roll-out of RDCT’s by forging strong partnerships with HCPs, participants, regulators and other relevant stakeholders
  • Scanning, characterizing available technologies to support RDCTs and applying design thinking processes to create a robust, end-to-end technology package

Kai Langel Director, R&D Operations Innovation Janssen

Karl-Ludwig Radek Associate Director, Strategic Account Lead, Global Clinical Operations Germany & Switzerland Janssen

Mira Zuidgeest Assistant Professor UMC Utrecht

5:55pm–7:25pm | Exhibition Hall

Networking drinks reception and interactive solution zone

6:45am–7:30amOutside

eyeforpharma morning run.

Start your day right and join the eyeforpharma team for a 5k run along Barcelona's beautiful coastline. All levels welcome. Meet at the AC Hotel reception for a 6.45 departure.

9:05am–9:25amBlue Room

Make patient engagement your new normal

  • Consistently be meeting best practice guidelines for systematic, meaningful patient engagement
  • Stay ahead of the game: Demand engagement to keep your competitive advantage as regulators signal a shift to making it expected
  • The Legal & Compensation Conundrum: How to derive fair market value for your patient network and set reasonable legal agreements to keep them coming back and contributing

Nicholas Brooke Executive Director Patient Focused Medicine Development

9:05am–9:25amRed Room

Deliver a personalised customer experience through marketing automation

  • Use marketing automation to create memorable customer journeys through the most relevant channels
  • Further improve CX by gathering and analysing data seamlessly through an integrated platform

Christian Scheuer VP, Global Commercial Affairs & Excellence LEO Pharma

9:05am–9:25amGreen Room

Enlighten medical decision-making with an integrated insights system

  • How to ensure real time insight is at the heart of your strategic decisions
  • Locate the insight source and turn insights into action for short and long term value to the business, HCP and patient
  • Ensure systems are purpose led, not technology – choosing the right system your needs

Victoria Ho Director, MSL Excellence EU/RoW Jazz Pharmacauticals

9:05am–9:25amPink Room

Pharma’s affordability complex: The need for more modern approaches to clinical trials to drive productivity and investment

  • Analysis of the observed productivity decline of the industry and how this is related to investments and supply
  • Discuss how new ways to run clinical trials could potentially improve productivity

Jorg Mahlich Head of HEOR Janssen

9:05am–9:25amOrange Room

Future therapy: the Novartis roadmap for Digital Therapeutics

  • See how Novartis is building digital therapies into its portfolio and the interplay with traditional therapies
  • How regulators and pharma need to evolve in cooperation for the benefit of patients

Jeremy Sohn VP, Global Head of Digital BD&L Novartis

9:05am–9:25amPurple Room

Say yes! Overcome perceived risks for new types of trial with unproven ROI

  • Feel the fear and do it anyway: How to determine an appropriate risk tolerance for pursuing unmet needs and betting on approval
  • Rework organisational responsibilities to break deadlocks, empower and support Clin Ops, and ensure trials are reimagined in a futureproof manner

Mohammed Ali Global Head Digital Development, Global Clinical Operations Boehringer Ingelheim

Bert Hartog Senior Director, Clinical Innovation Janssen

9:05am–10:05amRoundtable Zone

Roundtable dicussions: data privacy focus groups

Join our break out discussion groups about the changes we've already seen in data prviacy, and the road ahead for Europe and the rest of the world

9:25am–9:45amBlue Room

From digital health to DTx, how to gain adoption!

  • Don’t start with a solution, start with a problem
  • Focusing on patient needs alone is not enough to ensure widespread, impactful use
  • Consider the needs of all stakeholders to develop a core adoptable solution that can be scaled
  • Examples and lessons learned from real deployments

Jim O’Donoghue President S3 Connected Health

9:25am–9:45amPink Room

The when, what and why of early access – a new strategic approach

  • How to assess early access opportunities as requirements become an increasingly mainstream component of brand planning
  • Ensure synergy between early access and the commercial launch through aligning advocates and payer data requirements

9:25am–9:45amOrange Room

Activating the Ecosystem around DTx: a vital activity for enabling adoption

  • Why education and awareness are critical for every DTx initiative - the last mile
  • Importance of demonstrating the health economics of DTx - country stakeholder groups are champions
  • Proposing the investigation of a Joint European Assessment Framework for DTx

Jessica Shull European Lead Digital Therapeutics Alliance

9:45am–10:25amBlue Room

Panel: We all have a shared interest; better healthcare for patients

  • From small through to global organisations; discover what is best practice for engaging patient groups with various capabilities
  • You’re on the frontline, so lead from the front; why those in patient-centric roles must be the patients champion internally
  • The future is now: Understand how to pave the way for a new era of collaboration

Paul Robinson European Lead, Patient Innovation MSD

Olive Fulton Patient & Public Involvement Lead Asthma UK Centre for Applied Research

Vanessa Pott Director, Patient Advocacy & Strategic Partnerships Merck

Isabelle Bocher-Pianka Chief Patient Affairs Officer Ipsen

9:45am–10:25amRed Room

Create a holistic customer experience: break down silos to harness the combined power of commercial capabilities and medical authenticity

  • See the whole customer journey by aligning commercial and medical teams under one overarching engagement strategy, across all field and digital initiatives
  • Why education principles and disease led strategy are crucial to successful collaboration
  • Redefine “a good customer relationship” by leveraging combined insights and capabilities without tarnishing the valued authenticity of an independent medical affairs

Heather Moses Global Marketing Leader & Head of Medical Affairs Roche

Sandra Silvestri SVP, Global Head of Medical, China & Emerging Market Business Unit Sanofi

Ana Kostova AVP, Country Manager Germany Allergan

9:45am–10:25amGreen Room

Multi-case study session: Drive medical excellence with novel digital application

  • Maximise limited physician interaction time with data informed field force decision-making and content generation
  • Create new key stakeholder engagement opportunities with a focus on push over pull, using new technologies to catalyse HCP interactions across the customer journey
  • Provide medical education through virtual channels to increase efficiencies and reduce customer burden

Eddie Guzdar Medical Head of Neurology & Immunology (Rheumatology) Sanofi

Mark Johnson Director of Digital Engagements, Medical GSK

Caroline Phillips Senior Director, Global Medical Education at Medscape Medscape

9:45am–10:25amPink Room

Panel: HTA alignment – making European market access efficient

  • See the stakeholder engagement process behind the first successful joint HTA appraisals and price negotiations
  • Discuss how to reduce duplication of effort and ensure joint international assessment will translate into patient access on a local level
  • Understand what Common European Assessment models are proposed and how you can engage with their development

Anna Papin di Pompeo President Government Affairs - Europe Merck Group

9:45am–10:25amOrange Room

Panel: Exploring the physician and patient perspective on DTx: Is it in their consciousness?

  • Get an exclusive view into the physician’s perspective on DTx across 21 countries (via Ipsos’ Digital Doctor 2020 study)
  • Explore what “informed” patients think of the potential of DTx and how this effects their drivers and barriers to adoption (via Ipsos’ Patient Influencers study, in partnership with WEGO Health)

Reena Sangar Global Head, Connected Health Ipsos

9:45am–10:25amPurple Room

Panel: The new clinical ecosystem – who will be disrupted, who will be displaced?

  • Gain market maturity by comprehending today’s spectrum of different approaches – from centralized PIs to virtual and remote networks. An objective perspective on the landscape of approaches and where they’re headed
  • Why new marketplaces and automation could disrupt CROs whilst new data, could disrupt pharma development organizations
  • How technology can disrupt the fundamental nature of trial participation for patients and likely pathways to progression

Milind Kamkolkar Chief Digital Officer Cellarity

Michelle Shogren Director of Innovation - Pharma R&D Clinical Operations Bayer

10:05am–10:30amOrange Room

Partnership in practice: Happify and Sanofi’s new platform for patient engagement and quality of life

  • Why addressing key co-morbidities for individuals living with multiple sclerosis (MS), including depression and anxiety, digitally, opens new doors
  • Understand the key synergies such as relationships with large US health plans and employers
  • How the partnership conducted a global pilot study across 50 countries through social media, leveraging their existing consumer digital therapeutic platform

Chris Wasden Head of HappifyDTx Happify Health

10:25am–11:05am | Exhibition Hall

Coffee break, networking sessions and interactive solution zone

11:05am–11:30amBlue Room

The future is collaborative: How open innovation can enable patient-centric research

  • Understand how trust, mutual benefits and transparency can truly change the collaboration model
  • Explore how to engage a network of scientifically minded patients who can drive a new era of open innovation in R&D
  • Deliver patient relevant solutions by bridging the language gap between insights and research activities

Niclas Nilsson Head of R&D Open Innovation LEO Pharma

11:05am–11:30amRed Room

Case Study: Almirall’s Digital Garden that partners with start-ups to innovate together

  • Provide start-ups with the nutrients they need to grow into the next digital disruptor
  • Co-create cutting edge digital solutions when you provide pioneering start-ups leveraging pharma expertise
  • Learn how you can streamline your own operations through symbiotic sharing of information and processes

Francesca Wuttke Chief Digital Officer Almirall

11:05am–11:30amGreen Room

Case Study: Novartis’ AE Brain - AI that predicts adverse events and product complaints from your digital channels

  • Use AI to identify potential safety cases and product technical complaints across your complete digital channel spectrum, including chatbots, CRM notes, social media, apps and email. And its GxP too
  • Scale Xperience: A novel solution to scaling in a global enterprise solving compliance barriers, organisational silos, avoiding AI bias, adoption hurdles and sustainable funding

Abhimanyu Verma Lead, Applied Technology Innovation Novartis

11:05am–11:30amPink Room

Patients at the heart of cost-effectiveness analysis: NICE policies on measuring quality of life

  • Understand NICE’s policy on measuring and valuing QoL using EQ-5D-5L and what this means for your evidence package requirements
  • Insight into NICE’s support for research in emerging areas such as broader measures of quality of life (‘extending the QALY’) and measuring and valuing quality of life in children

Rosie Lovett Senior Scientifc Advisor NICE

11:05am–11:30amOrange Room

Get approved: understand Medical Device Regulations (MDR) and requirements from Notified Bodies

  • Balance evolving products with the rigour required for a safe regulatory environment
  • Examine the Notified Body’s interpretation and how to shepherd your product through to market

Robert Madjino Director, Clinical Assessment TUV SUD

11:05am–11:30amPurple Room

Build a collaborative development framework for novel digital endpoints

  • To put the patient at the centre, determine how to define meaningful novel digital endpoints
  • Leverage existing guidance and processes and account for technical complexity in endpoint development
  • How a collaborative business model enables you to fast-track development and improve reliability
  • An assessment of fit-for-purpose technology that enables quick adoption without losing flexibility

Kai Langel Director, R&D Operations Innovation Janssen

11:30am–11:50amRed Room

Medicine and the Machine: the power and pitfalls of artificial intelligence and how it will change modern medicine.

  • Discuss the groundbreaking ideas of Medscape Editor-in-Chief Eric Topol, MD, and clinician, Abraham Verghese, MD on the intersection of artificial intelligence with the practice of modern medicine
  • Discover how medical outcomes are adversely affected by a chronic and insidious culprit: The loss of humanity in medicine
  • Examine Artificial Intelligence as an unlikely humanitarian hero and our best chance at bringing time and presence back to patient care

Ben Greenberg CPO Scripps Research Translational Institute, Medscape Contributor Medscape

11:30am–11:50amGreen Room

Practical use of big data in medical affairs: Driving MSL engagement, insight, and outcomes through data and analytics

  • How to engage key opinion leaders using big data to empower medical field-based teams with new insight – best-in-class case studies
  • Implement an evidence-based “data practice” to drive better organizational and clinical outcomes

Kelly Malloy VP, Project Strategy, Publication Planning Anju Software

Alexandra Moens Director, Clinical & Commercial Strategy, Data Division Anju Software

11:50am–1:00pmWorkshop Rooms

Break-Out Interactive Workshop Sessions (Pharma and Biotech only)

  • Pick from 10 different interactive break-out sessions fostering hands-on learning and open discussion in a more personal setting
  • Sign up for these limited space sessions via the \"interactive sessions\" section of your eyeforpharma Barcelona app

1:00pm–2:00pm | Exhibition Hall

Lunch, networking session and interactive solution zone

2:00pm–2:20pmBlue Room

Challenge the ‘old pharma’ mindset with evidence-based outcomes

  • Empower the patients voice in-house and convince all functions of its value by developing measurable insights
  • Break down silos to swiftly incorporate the patient’s perspective when developing new services

Geoff Rollason Patient Experience & Service Director - Oncology Pfizer

2:00pm–2:20pmRed Room

Enhance the capabilities of your customer facing team using AI insights

  • Design a comprehensive ‘customer persona’ profile to fully understand and meet individual customer need
  • Perfect your omnichannel strategy with quality insights generated through cutting edge AI

Stefano Zagnoni Head of Digital & Innovation Janssen

2:00pm–2:20pmGreen Room

Case study: Achieve RWE-only regulatory label expansion

  • Why an RWE-only submission strategy meant lower costs and overall faster approval process in comparison to the traditional study process
  • Agree on study design and methodology with early regulatory engagement
  • How to ensure regulatory-standard RWD - the steps taken to ensure data sources were appropriate and of high quality, ensuring credibility

Chris Boone VP, Global Medical Epidemiology & Big Data Analysis Pfizer

2:00pm–2:20pmPink Room

Case Study: Use patient-centered evidence to influence market access deicsion-making

  • Influence HTA and payer decision making by translating qualitative PRO evidence into more traditional value formats
  • Understand how to review QOL, carer and patient feedback, and other patient focused endpoints
  • Explore recent developments in patient engagement framework and PRO submission guidelines when working with the FDA

Stefan Holmstrom Global Head, PRO Excellence & HTA Strategy Astellas

2:00pm–2:20pmOrange Room

Germany's Law for Digital Health Reimbursement (DVG)

  • Understand the inner workings of Germany’s ground-breaking policy and new thoughts on how to treat patients
  • Learn about the criteria set by BfArM and what the medical community is thinking

Henrik Matthies Managing Director Health Innovation Hub

2:00pm–2:20pmPurple Room

Digital recruitment with depth – how Novartis will increase trial participation

  • An enhanced approach to trial awareness and recruitment which combines broad channels/materials with specific identification of suitable candidates
  • Detaching physician attachment from eligibility – enabling through technology
  • How a multichannel approach can be used to increase awareness and also understand patient profiles. Two-way use of data to enable patent centric trials

Sam Hariry Head of Clinical Strategy & Operations Novartis

2:00pm–3:00pmRoundtable Zone

Medical Leadership Roundtable Discussions

Join colleagues from across the industry for a 60 minute in-depth discussion around how we can push Medical leadership across the whole company

2:20pm–2:40pmPurple Room

Accessing Meaningful Subject Data and Clinical Insights Throughout the Clinical Trial Process

  • Discover how to obtain critical insights into real- time engagement and why they can be the key difference between staying in treatment and discontinuation

Rich Christie Chief Development Officer AiCure

2:20pm–2:40pmBlue Room

Bring your Patient Support Program out of the dark

  • Hear how a real life Patient Support Program was turbocharged by linking actual patient medicine usage, in real-time, to the PSP’s dashboard
  • Phillips-Medisize, as one of the few companies to have made this connection in a marketed drug product, will share our experiences of building and running such a system – from drug to data
  • Linking medicine usage, in real-time, to PSP’s not only provides the light needed to focus PSP activities, but also helps sales and marketing teams monitor, and respond to, medicine usage patterns including compliance and persistence

Kevin Deane VP and Head of Digital Health Phillips-Medisize, a Molex Company

2:20pm–2:40pmOrange Room

Panel: The pathway to prescriptions: navigate the varying national regulatory & reimbursement criteria in France, Belgium and the UK

  • Examine the plans and intentions of each of the national institutions currently reimbursing DTx
  • Gain true comprehension of what has led us to this point and the nuances of how reimbursement is projected over the next 5 years

Steven Vandeput Advisor Extramuros & Digital Health beMedTech

Chris Chesters Senior Scientific Adviser NICE

Sam Shah Global Clinical & Digital Advisor, Healthcare UK Department for International Trade

2:40pm–3:00pmBlue Room

“Transforming” care delivery through new partnership models with healthcare

  • Examine why AstraZeneca created a strategy for growth by connecting innovation to patient centricity
  • Case Study: Discover-NOW; how this new collaborative innovation-hub will gather real world evidence to better monitor and manage patients with Type-2 Diabetes

Adam Higgins Senior Director, Digital Health, Patient & Value Solutions AstraZeneca

Amanda Lucas Commercial Director Imperial College

2:40pm–3:00pmRed Room

Google’s challenge to pharma: a patient-centric approach to insights and data

  • Use insights garnered around your consumer as the central pillar of your patient-centric approach
  • Create a better understanding of the health-tech ecosystem to satisfy your marketing needs

Stefani Klaskow Head, Industry Google

2:40pm–3:00pmGreen Room

Case Study: Bridging the divide between US and EU common data models

  • How the CPRD are translating UK patient records into the FDAs Sentinel Programme and IMI EHDEN’s common data models to extend pharmacovigilance across continents

Janet Valentine Director of the CPRD CPRD

2:40pm–3:00pmPink Room

Innovative Value Based Solutions – The Good, The Bad and The Ugly

  • Global case studies deep diving into the world of beyond rebate value negotiations
  • Pharma and payer compare and contrast: a unique perspective

Diar Fattah Global Director, Innovative Value Strategies and Evidence AstraZeneca

2:40pm–3:00pmOrange Room

PANEL: Getting paid: how leading companies have journeyed to reimbursement across the EU

  • Hear the twists and tales as early trailblazers have sought to become viable businesses

Rossana Alessandrello Coordinator of Innovation & Value Based Procurement AQuAS

Maryne Cotty-Eslous Founder Lucine

Adam Kirk Clinical Director My mHealth

Lloyd Humphreys Head of Europe SilverCloud Health

Sam Shah Global Clinical & Digital Advisor, Healthcare UK Department for International Trade

2:40pm–3:00pmPurple Room

Build a global digital support network that enables full rollout in multiple territories

  • Find technology providers who can develop and distribute medicines, IoT-type devices, sensors, variables into people’s homes in a global setting
  • Build a coalition of partners that ensure your trials deliver effectiveness in new regions

Bert Hartog Senior Director, Clinical Innovation Janssen

3:20pm–4:00pm | Exhibition Hall

Coffee break, networking sessions and interactive solution zone

4:00pm–4:20pmBlue Room

Case Study: Beyond the medicine: Co-creating solutions that meet real world patient and HCP needs

  • Explore 3 projects from Roche Innovation Lab and hear about the journey behind each project from first interaction to final solutions
  • Understand how each solution deliver value to the users by getting insights in user feedback and Roche’s learnings

Jonas Kierkegaard Head of Innovation Lab Roche

4:00pm–4:20pmRed Room

Case Study: Effectively mix content using AI

  • Understand why and how GSK have invested in AI and Machine Learning
  • Glimpse the future of pharma where AI is central to every operation

Denise Dewar Digital Hub Director, Europe GSK

4:00pm–4:20pmGreen Room

How to win friends and influence trial design

  • Use of RWE to enhance clinical development, from clinical trial design to determining additional evidence needs
  • Successful (and unsuccessful) examples of using RWE to influence early decision making and some practical examples of how to overcome these challenges
  • The next steps pre-launch RWE application – creating more efficient trials, accelerating the time to decision making and augmenting clinical trials with RWE

Michael Lees Head of Access-Centred Evidence Planning Takeda

4:00pm–4:20pmOrange Room

Panel: Work with the patient as a partner to co-create and co-evolve digital therapies

  • Establish a patient-first mindset and understand the best ways to facilitate patient involvement in your development
  • Incorporate the science of behaviour change to provide greater traction and outcomes for patients
  • Explore ways to raise digital adherence and better patient outcomes

David Verdura Chief Operating Officer Curelator

Enric Barba Ibañez Patient & Digital Health Advocate

Door Vonk Founder Tired of Cancer

Olivier Jarry President & Chief Commercial Officer DarioHealth

4:00pm–4:20pmPurple Room

Interoperability – both technology and people – as the greatest win for patient care

  • Stop paralyzing your research – find ways to reduce the interoperability burden from the outset and get closer to the universal HER
  • Trust as the key currency for building an alliance for data sharing and efficient coalition between multiple institutions
  • How to work with regulators – understand the FDA/EMA mindset, build alliances and secure acceptance for your innovations

Joy Bhosai Chief of Digital Health & Strategy Duke University

4:00pm–5:00pmRoundtable Zone

Patient-led Patient Engagement Roundtables

Join our patient leaders to explore new solutions to working with patient advocacy organisations.

4:40pm–5:00pmBlue Room

Case Study: achieve commercial excellence with a patient-centric framework to pioneer patient access

  • Streamline your commercial strategy by holistically assessing and addressing unmet customer needs
  • Boost efficiency with Sandoz’s framework introducing integrated marketing and sales agenda

Alexey Cherchago Head of Sales Excellence Europe Sandoz

4:40pm–5:00pmRed Room

Closed-loop marketing: An integrated channel approach for consistent success

  • Ensure marketing, IT and external alignment to make sure capabilities are there to back-up marketing innovations
  • Make informed channel and content selection decisions by creating a backbone infrastructure that allows data flow across the company

Andreas Dach Digital & Multi-Channel Lead Eli Lilly

4:40pm–5:00pmGreen Room

Case study: Aligning regulatory and HTA decision-making around RWE assessment - CAT Initiative

  • Overview of the barriers and limitation to uptake of RWE in regulatory and HTA decision-making in Canada
  • Discuss the design and implementation of a national multi-stakeholder “Core Action Team” (CAT) to establish and improve use and uptake of RWE in decision-making
  • How CAT’s novel approach is improving collaboration between industry, regulators, HTA, payers, and researchers increasing RWE’s impact

Tarry Ahuja RWE Lead & Manager, Policy & Product Development Canadian Agency for Drugs & Technology in Health

4:40pm–5:00pmPink Room

Case study: The evolution of HTA frameworks to accelerate patient access to innovative cancer treatments

  • Explore how Janssen is driving HTA innovation in Europe to match increasing cancer treatment effectiveness and reduced EoL (end of life) data
  • Lessons learnt from recent regulatory innovations to assess surrogate endpoints and novel evidence submissions
  • How to prepare for the future of HTA evidence generation requirements for access

Clare Hague Market Access Lead, Hematology, EMEA Janssen

4:40pm–5:00pmOrange Room

Fireside chat: Standalone or integrated? Determine whether DTx should be a separate business unit within your company

  • Discuss what is the catalyst for your DTx products and explore how this should inform its commercial and operational purpose

Francesca Wuttke Chief Digital Officer Almirall

Stephen Dunne Chief Digital Therapeutics Officer Alpha

4:40pm–5:00pmPurple Room

End to end clinical trials using patient records: run randomised trials entirely based on real world data

  • Hear how the CPRD are combing PRO & EHR to assess clinical effectiveness purely from RWD sets

Janet Valentine Director of the CPRD CPRD

5:00pm–5:40pmBlue Room

Panel: Empower commercial decision-making: Bring data from every interaction together

  • Define your digital investment strategy by creating a continuous feedback loop of engagement activity
  • Match the right data with the right internal usage to increase the efficiency of your analytics approach
  • Give reps and marketing strategists the advantage with a backbone infrastructure that links together separate systems spreading of insights and data throughout the business 

Renaud Sermondade VP, Global Head of Insights and Analytics Sanofi

Christophe Dufour Director, Innovation, Data & Customer eXperience AstraZeneca

5:00pm–5:40pmRed Room

Panel: Create an adaptive field force to meet customer expectations in the digital world

  • Find balance between virtual engagements and infield activity to ensure relationship building remains personal
  • Optimise rep engagement by ensuring the value of digital capabilities is clearly demonstrated, fostering greater transformation
  • Define the evolving role of the rep in the era of increased medical engagement, whilst increasing collaboration to create a seamless customer experience

Pieter De Muynck Global Marketing Leader - Global Commercial Strategy Organization Janssen

Rodney Smith VP, Head of Medical Affairs Europe Daiichi Sankyo

Hélène Tixier VP, Head Global Digital & Multichannel strategy Sanofi Pasteur

5:00pm–5:40pmGreen Room

Panel:Generate RWE pre-approval to expand access and better inform pricing negotiations

  • Better inform dossier submissions with new forms of evidence, such as comparative efficacy and cost to hospital, not traditionally part of RCT’s scope with concurrent RWE studies
  • Gain internal buy-in by working with regulators to inform evidence collection and use strategy - Discuss next steps toward a new development paradigm with normalised RWE generation inclusion and reduced RCT reliance

Anjan Chatterjee VP, Real World Evidence - COE, Epidemiology and Big Data Boehringer Ingelheim

Sam Hariry Head of Clinical Strategy & Operations Novartis

Chris Boone VP, Global Medical Epidemiology & Big Data Analysis Pfizer

Pall Jonsson Associate Director, Science Policy and Research NICE

5:00pm–5:40pmPink Room

Panel: Reform or Revolution? Achieve affordable pricing for curative and predictive medicines

  • Learn how existing CAR-T and gene therapy agreements use RWE to demonstrate the long-term value of their treatments, whilst overcoming data quality deficiencies and methodology challenges
  • Discuss how to engage early with authorities to find flexible performance schemes that share risk fairly between both parties
  • Explore proposals on how to measure the long-term healthcare impact of preventive and curative treatments to satisfy HTA assessment

Alexander Natz Secretary General EUCOPE

Clare Hague Market Access Lead, Hematology, EMEA Janssen

Tamir Singer Head of Commercial Access & Value, Commercial Medicines Directorate NHS England

5:00pm–5:40pmOrange Room

Panel: Harness the DTx data opportunity: insight from gathering RWE on the front lines

  • How to develop an effective feedback loop to ensure your product evolution is based on solid evidence
  • Are you using data well? Understand the multiple utilities of good data stewardship in seeking patient access and value
  • Determine the outcomes-based agreements you may be able to forge through exemplary data

Austin Speier Chief Strategy Officer Click Therapeutics

No results for 1181.

Simon Leigh Head of Research & Value Demonstration Orcha

Ramon Hernandez Vecino Head of Real-World Evidence Data & Analytics Sanofi

5:00pm–5:20pmPurple Room

Merging man and machine: Unleash the potential of data to empower patients

  • Recruit patient cohorts with easily accessible technology and meet them in the most convenient place possible – their home
  • Improve both quality and breadth of data generated through PROs by exploiting trending wearable technology

Celine Ulmann Head of Digital Innovation R&D Almirall

5:20pm–5:40pmPurple Room

The Clinical Entrepreneur: how agility will be a necessity for successful digitization of the trial

  • Examples of Lundbeck’s efforts to rewrite clinical planning & execution through a faster, iterative, learning model
  • Man vs machine – understand how to balance resources in a smarter way
  • A fresh perspective on the steps required to get your trial from idea to infinity

Mads Dalsgaard Senior Vice President, Head of Experimental Medicine & Clinical Development Lundbeck

5:40pm–6:40pm | Exhibition Hall

Networking drinks reception in the exhibition hall

6:00pm–7:50pm | Hilton Diagonal Mar

The Pharma Networking Party - located at the newly renovated rooftop Puro Beach bar at the Hilton Diagonal Mar

6:45am–7:30amOutside

eyeforpharma morning run.

Start your day right and join the eyeforpharma team for a 5k run along Barcelona's beautiful coastline. All levels welcome. Meet at the AC Hotel reception for a 6.45 departure.

9:00am–9:05amPurple Room

Chairman Opening

9:05am–12:55pmPurple Room

Closing c-suite keynote sessions

Key themes include:

  • Authentic Leadership: ensure integrity and accuracy in decision-making and portfolio design. Gain healthcare’s trust through medically-driven content, customer innovation and holistic patient solutions
  • New ways to reach commercial goals: turn HCPs into influencers and inspire patient champions. Use content, education, empowerment and open innovation to harness external relationships
  • From drugs to treatments: use cloud platforms, data insights and joint ventures with startups to generate a new suite of digital products, value-added services and cell/gene therapies. Go from druggable & reactive to curable & preventative
  • Digitise evidence: prepare a superior mix of virtual clinical trials and regulatory-grade RWE to gain authorisation, widen access, boost launch and drive patient outcomes

More session details to follow

Alberto Martinez CEO Mundipharma

Camilla Harder Hartvig SVP, International Business Alexion

Jeffrey Wren EVP, Neurology Patient Value Head UCB

A Reuters News-led Panel Reuters

9:30am–9:55amPurple Room

Searching for a drug pricing solution: Ideas from around the globe

The panel will discuss how to balance medical advances with affordability*

Moderators: Axel Threlfall Editor-at-Large Reuters

Caroline Humer Health & Pharma Correspondent Reuters


Panellists: Steve Miller EVP, Chief Clinical Officer Cigna

Peter Bach Director Memorial Sloan Kettering Cancer Center

Further panellists to be released next month

*Reuters editorial operates independently from Reuters commercial operations.

12:25pm–2:00pm | Exhibition Hall

Seated 3 course networking banquet

2:00pm–2:00pm | Centre Convencions Internacional Barcelona

End of conference

Return to top